Are you Dr. Sandrock?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
15 Parkman St
Wac 835 Neurology Associates
Boston, MA 02114Phone+1 617-724-3914Fax+1 617-726-6991- Is this information wrong?
Summary
- Dr. Alfred Sandrock Jr., MD is a board certified neurologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1989 - 1992
- Massachusetts General HospitalInternship, Internal Medicine, 1988 - 1989
- Harvard Medical SchoolClass of 1988
Certifications & Licensure
- MA State Medical License 1990 - 2019
- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2 citationsOverall Disability Response Score: An integrated endpoint to assess disability improvement and worsening over time in patients with multiple sclerosis.Ih Chang, Ludwig Kappos, Gavin Giovannoni, Peter A Calabresi, Alfred Sandrock, Wenting Cheng, Shan Xiao, Katherine Riester, Shibeshih Belachew, Aaron Deykin, Bing Zhu> ;Multiple Sclerosis. 2022 Dec 1
- 10 citationsAlzheimer disease neuropathology in a patient previously treated with aducanumab.Edward D Plowey, Thierry Bussiere, Raj Rajagovindan, Jennifer Sebalusky, Stefan Hamann, Christian von Hehn, Carmen Castrillo-Viguera, Alfred Sandrock, Samantha Budd Ha...> ;Acta Neuropathologica. 2022 Jul 1
- 5 citationsMeasuring treatment response to advance precision medicine for multiple sclerosis.Peter A. Calabresi, Ludwig Kappos, Gavin Giovannoni, Tatiana Plavina, Irene Koulinska, Michael R. Edwards, Bernd C. Kieseier, Carl de Moor, Elias S. Sotirchos, Elizabe...> ;Annals of Clinical and Translational Neurology. 2021 Oct 26
- Join now to see all
Press Mentions
- Could Alzheimer’s Disease Be Eradicated? Here’s What We Know — and What We Don’tMay 5th, 2023
- The FDA’s Accelerated Approval Process: When Drugs Are Cleared for Sale Based on Limited EvidenceOctober 18th, 2021
- Biogen in a Bind: The High-Stakes Fight over Alzheimer’s and What Makes a Drug WorthwhileJuly 25th, 2021
- Join now to see all